RB1 and neoplasm: There is preliminary evidence suggesting that molecular aberrations of both TP53 and RB1 may impact the tumor microenvironment as shown in a global study of more than 10,000 patients from The Cancer Genome Atlas (TCGA) that also included patients with MIBC [14].